comparemela.com
Home
Live Updates
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain : comparemela.com
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
The Broad Patent Coverage is a Major Milestone for the Commercial Success of Jan123
LAS VEGAS, Aug. 29, 2023 /PRNewswire/ -- JanOne , the visionary biotech company dedicated to discovering...
Related Keywords
Tony Isaac ,
Tony Giordano ,
Amol Soin ,
Exchange Commission ,
Janone Inc ,
Us Patent Office ,
Broad Patent Coverage ,
Major Milestone ,
Commercial Success ,
Chief Scientific ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.